Primary Site >> Biliary tract Cancer
Gene >> RRM1
| 1. | |||||||||||
| Journal: | Oncol Rep. 2008 Aug;20(2):279-86. | ||||||||||
| Title: | Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma. | ||||||||||
| Author: | Ohtaka, Kazuma|Kohya, Naohiko|Sato, Ken|Kitajima, Yoshihiko|Ide, Takao|Mitsuno, Mayumi|Miyazaki, Kohji | ||||||||||
| PMID: | 18636187 | ||||||||||
| 2. | |||||||||||
| Journal: | Lancet Oncol. 2011 Jul;12(7):693-702. | ||||||||||
| Title: | The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer. | ||||||||||
| Author: | Jordheim, Lars Petter|Seve, Pascal|Tredan, Olivier|Dumontet, Charles | ||||||||||
| PMID: | 21163702 | ||||||||||
| 3. | |||||||||||
| Journal: | Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1659-63. | ||||||||||
| Title: | Ribonucleotide reductase M1 expression in intrahepatic cholangiocarcinoma. | ||||||||||
| Author: | Wakai, Toshifumi|Shirai, Yoshio|Sakata, Jun|Takamura, Masaaki|Matsuda, Yasunobu|Korita, Pavel V|Muneoka, Katsuki|Sasaki, Masataka|Ajioka, Yoichi|Hatakeyama, Katsuyoshi | ||||||||||
| PMID: | 21940346 | ||||||||||
| 4. | |||||||||||
| Journal: | Invest New Drugs. 2012 Dec;30(6):2148-60. | ||||||||||
| Title: | The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines. | ||||||||||
| Author: | Nam, Hyun-Jin|Kim, Hwang-Phill|Yoon, Young-Kwang|Song, Sang-Hyun|Min, Ah-Rum|Han, Sae-Won|Im, Seock-Ah|Kim, Tae-You|Oh, Do-Youn|Bang, Yung-Jue | ||||||||||
| PMID: | 22197904 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer. 2013 Jan 15;119(2):454-62. | ||||||||||
| Title: | Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. | ||||||||||
| Author: | Fisher, Sarah B|Fisher, Kevin E|Patel, Sameer H|Lim, Matthew G|Kooby, David A|El-Rayes, Bassel F|Staley, Charles A 3rd|Adsay, N Volkan|Farris, Alton B 3rd|Maithel, Shishir K | ||||||||||
| PMID: | 22760605 | ||||||||||
| 6. | |||||||||||
| Journal: | World J Surg Oncol. 2013 May 27;11:117. | ||||||||||
| Title: | Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone. | ||||||||||
| Author: | Murata, Akihiro|Amano, Ryosuke|Yamada, Nobuya|Kimura, Kenjiro|Yashiro, Masakazu|Nakata, Bunzo|Hirakawa, Kosei | ||||||||||
| PMID: | 23710668 | ||||||||||
| 7. | |||||||||||
| Journal: | Br J Cancer. 2014 Sep 23;111(7):1275-84. | ||||||||||
| Title: | Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy. | ||||||||||
| Author: | Sasaki, H|Murakami, Y|Uemura, K|Sudo, T|Hashimoto, Y|Kondo, N|Sueda, T | ||||||||||
| PMID: | 25032731 | ||||||||||
| 8. | |||||||||||
| Journal: | Int J Clin Exp Med. 2014 Dec 15;7(12):5041-9. eCollection 2014. | ||||||||||
| Title: | Gemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer. | ||||||||||
| Author: | Deng, Ting|Pan, Hong|Han, Rubing|Huang, Dingzhi|Li, Hongli|Zhou, Likun|Wang, Xia|Bai, Ming|Li, Xiang|Liu, Rui|Ge, Shaohua|Ning, Tao|Zhang, Le|Ba, Yi | ||||||||||
| PMID: | 25664003 | ||||||||||
| 9. | |||||||||||
| Journal: | HPB (Oxford). 2015 Dec;17(12):1119-23. | ||||||||||
| Title: | Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. | ||||||||||
| Author: | Potkonjak, Mary|Miura, John T|Turaga, Kiran K|Johnston, Fabian M|Tsai, Susan|Christians, Kathleen K|Gamblin, T Clark | ||||||||||
| PMID: | 26374242 | ||||||||||
| 10. | |||||||||||
| Journal: | Oncology. 2015;89(6):345-50. | ||||||||||
| Title: | Cytidine Deaminase as a Molecular Predictor of Gemcitabine Response in Patients with Biliary Tract Cancer. | ||||||||||
| Author: | Yoon, Kyong-Ah|Woo, Sang Myung|Hong, Eun Kyung|Jung, Mee Kyung|Park, Weon Seo|Bae, Kieun|Han, Sung-Sik|Kim, Tae Hyun|Koh, Young Hwan|Park, Sang-Jae|Lee, Woo Jin | ||||||||||
| PMID: | 26418006 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncotarget. 2017 Jul 6;8(46):81394-81404. | ||||||||||
| Title: | DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study. | ||||||||||
| Author: | Woo, Sang Myung|Yoon, Kyong-Ah|Hong, Eun Kyung|Park, Weon Seo|Han, Sung-Sik|Park, Sang-Jae|Joo, Jungnam|Park, Eun Young|Lee, Ju Hee|Kim, Yun-Hee|Kim, Tae Hyun|Lee, Woo Jin | ||||||||||
| PMID: | 29113399 | ||||||||||